Watson Sues FDA To Regain Exclusivity For Generic Actos
Generic-drug maker Watson Laboratories Inc. sued the U.S. Food and Drug Administration on Wednesday in Washington federal court, claiming the agency is attempting to rob Watson of a 180-day marketing exclusivity...To view the full article, register now.
Already a subscriber? Click here to view full article